Increased levels of nerve growth factor in the airways of patients with sarcoidosis

Journal of Internal Medicine

Volumn 264, Issue 5, 2008, Pages 463-471

  Dagnell, C ^a,b   Grunewald, J ^a,b   Idali, F ^a,b   Wiken M ^a,b   Kemi, C ^a,b   Skold C M ^a,b   Planck, A ^a,b,c   Newman, L S ^d   Eklund, A ^a,b   Olgart Hoglund C ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Kärnsjukhuset I Skövde ^*  (Sweden)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Bronchoalveolar lavage; Lung; Neurotrophins; Pulmonary inflammation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; NERVE GROWTH FACTOR;

ADULT; AIRWAY; ARTICLE; BERYLLIOSIS; BRONCHUS SECRETION; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATION; LOFGREN SYNDROME; LUNG LAVAGE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN SECRETION; SARCOIDOSIS;

ACUTE DISEASE; ADULT; BERYLLIOSIS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; EOSINOPHILS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; SARCOIDOSIS, PULMONARY; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 53549130003     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01988.x     Document Type: Article

References (33)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999 160 : 736 55.
2. Grunewald J, Eklund A. Gender specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med 2007 175 : 40 4.
3. Olgart Hoglund C, Frossard N. Nerve growth factor and asthma. Pulm Pharmacol Ther 2002 15 : 51 60.
4. Olgart Hoglund C, de Blay F, Oster J et al. Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J 2002 20 : 1110 6.
5. Virchow J, Julius P, Lommatzsch M, Luttmann W, Renz H, Braun A. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med 1998 158 : 2002 5.
6. Kassel O, de Blay F, Duvernelle C et al. Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy 2001 31 : 1432 40.
7. Hope-Gill BD, Hilldrup S, Davies C, Newton RP, Harrison NK. A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003 168 : 995 1002.
8. Ricci A, Graziano P, Bronzetti E et al. Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis 2007 24 : 13 23.
9. Ricci A, Mariotta S, Saltini C et al. Neurotrophin system activation in bronchoalveolar lavage fluid immune cells in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 : 186 94.
10. Ricci A, Felici L, Mariotta S et al. Neurotrophin and neurotrophin receptor protein expression in the human lung. Am J Respir Cell Mol Biol 2004 30 : 12 9.
11. Braun A, Appel E, Baruch R et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998 28 : 3240 51.
12. de Vries A, Dessing MC, Engels F, Henricks PA, Nijkamp FP. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1999 159 : 1541 4.
13. Path G, Braun A, Meents N et al. Augmentation of allergic early-phase reaction by nerve growth factor. Am J Respir Crit Care Med 2002 166 : 818 26.
14. Micera A, Vigneti E, Pickholtz D et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A 2001 98 : 6162 7.
15. Kohyama T, Liu X, Wen F et al. Nerve growth factor stimulates fibronectin-induced fibroblast migration. J Lab Clin Med 2002 140 : 329 35.
16. Nassenstein C, Schulte-Herbruggen O, Renz H, Braun A. Nerve growth factor: the central hub in the development of allergic asthma? Eur J Pharmacol 2006 533 : 195 206.
17. Planck A, Eklund A, Grunewald J. Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients. Eur Respir J 2003 21 : 52 7.
18. Newman LS, Kreiss K, King Jr. TE, Seay S, Campbell PA. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis 1989 139 : 1479 86.
19. Eklund A, Blaschke E. Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax 1986 41 : 629 34.
20. Idali F, Wiken M, Wahlstrom J et al. Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J 2006 27 : 451 9.
21. Lang UE, Gallinat J, Danker-Hopfe H, Bajbouj M, Hellweg R. Nerve growth factor serum concentrations in healthy human volunteers: physiological variance and stability. Neurosci Lett 2003 344 : 13 6.
22. Corsi MM, Dogliotti G, Pedroni F et al. Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway. Neuro Endocrinol Lett 2006 27 : 773 8.
23. Martocchia A, Sigala S, Proietti A et al. Sex-related variations in serum nerve growth factor concentration in humans. Neuropeptides 2002 36 : 391 5.
24. Newman LS. Immunologic mechanisms in granulomatous lung disease. Immunopharmacology 2000 48 : 329 31.
25. Olgart C, Frossard N. Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. Eur Respir J 2001 218 : 115 21.
26. Kemi C, Grunewald J, Eklund A, Olgart Hoglund C. Differential regulation of neurotrophin expression in human bronchial smooth muscle cells. Respir Res 2006 7 : 18.
27. Ma D, Wolvers D, Stanisz AM, Bienenstock J. Interleukin-10 and nerve growth factor have reciprocal upregulatory effects on intestinal epithelial cells. Am J Physiol Regul Integr Comp Physiol 2003 284 : R1323 9.
28. Bayas A, Kruse N, Moriabadi NF et al. Modulation of cytokine mRNA expression by brain-derived neurotrophic factor and nerve growth factor in human immune cells. Neurosci Lett 2003 335 : 155 8.
29. Nassenstein C, Braun A, Erpenbeck VJ et al. The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma. J Exp Med 2003 198 : 455 67.
30. Ziegenhagen MW, Rothe ME, Schlaak M, Muller-Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003 21 : 407 13.
31. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci U S A 1989 86 : 10059 63.
32. Torcia M, Bracci-Laudiero L, Lucibello M et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996 85 : 345 56.
33. Ohrn MB, Skold CM, van Hage-Hamsten M, Sigurdardottir O, Zetterstrom O, Eklund A. Sarcoidosis patients have bronchial hyperreactivity and signs of mast cell activation in their bronchoalveolar lavage. Respiration 1995 62 : 136 42.